Abbott Laboratories – Consensus ‘buy’ rating and 13.5% Upside Potential

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Abbott Laboratories which can be found using ticker (ABT) now have 21 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The target price High/Low ranges between 144 and 103 calculating the average target price we see $124.87. Given that the stocks previous close was at $110.05 this would indicate that there is a potential upside of 13.5%. It’s also worth noting that there is a 50 day moving average of $104.12 and the 200 day MA is $105.33. The company has a market cap of 192.48B. The stock price is currently at: 110.49 USD

The potential market cap would be $218,404,522,652 based on the market consensus.

USD

The company has a dividend yield of 1.35%. Other points of data to note are a P/E ratio of 33.58, revenue per share of 23.75 and a 6.3% return on assets.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search